Disambiguation evidence for panitumumab via surface form

"panitumumab"

Triples (2)

Triples where some other subject referred to this entity as "panitumumab".

FOLFIRI regimen → oftenCombinedWith →
"panitumumab"
↳ resolves to panitumumab
ⓘ
EGFR → targetOfDrug →
"panitumumab"
↳ resolves to panitumumab
ⓘ